Results 51 to 60 of about 11,237 (163)

Morphological and immunohistochemical features of placenta in postpartum women with hyperprolactinemia history

open access: yesPatologìâ, 2020
Hyperprolactinemia (HP) is a persistent increase in serum prolactin levels, the most typical manifestation of which is a dysfunction of the reproductive system.
T. D. Zadorozhna   +3 more
doaj   +1 more source

Comparison of Side Effects Between 3‐Monthly and 1‐Monthly Paliperidone Palmitate Formulations in Patients With Schizophrenia

open access: yesHuman Psychopharmacology: Clinical and Experimental, Volume 41, Issue 1, January 2026.
ABSTRACT Background The paliperidone palmitate 3‐month (PP3M) formulation offers an extended dosing interval compared to the 1‐month (PP1M) formulation. However, data on the comparative side effect profiles of PP1M versus PP3M in real‐world settings remain limited.
Erkan Kuru   +3 more
wiley   +1 more source

Development of Hyperprolactinemia Induced by the Addition of Bupropion to Venlafaxine XR Treatment

open access: yesBezmiâlem Science, 2018
Hyperprolactinemia is characterized by abnormally increased serum prolactin levels. Menstrual irregularities and hyperprolactinemia can be caused by a variety of medical conditions as well as due to the use of some psychopharmacological drugs, namely ...
Alperen KILIÇ   +3 more
doaj   +1 more source

Occurrence of Potential Prescribing Cascades After Hospital Discharge: A Cohort Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Purpose A prescribing cascade (PC) occurs when a medication (index) causes an adverse drug reaction (ADR), which is addressed by prescribing additional medication (marker). Medication initiated in the hospital may cause post‐discharge ADRs and PCs, especially when multiple healthcare providers are involved.
Atiya K. Mohammad   +7 more
wiley   +1 more source

Decrease in serum prolactin levels after long-acting injectable aripiprazole treatment: a case report

open access: yesPsychiatry and Behavioral Sciences, 2017
Hyperprolactinemia is a severe problem which involves galactorrhea, amenorrhea, sexual dysfunction, and lowered bone mineral density. It can be a long-lasting problem belongs to the atypical antipsychotics that impairs treatment adherence and quality of ...
Orkun Aydin, Pinar Unal-Aydin
doaj   +1 more source

Prevalence and Characteristics of Women With Polycystic Ovary Syndrome and Isolated Diagnostic Feature: A Nationwide Cross‐Sectional Survey

open access: yesReproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose This cross‐sectional survey aimed to determine the prevalence and characteristics of polycystic ovary syndrome (PCOS) and its isolated diagnostic features among Bangladeshi women aged 10–45 years, utilizing the 2023 International Evidence‐Based Guidelines, incorporating anti‐Mullerian hormone (AMH).
Md Shahed‐Morshed   +21 more
wiley   +1 more source

Retrospective Analysis of Cushing’s Disease with or without Hyperprolactinemia

open access: yesInternational Journal of Endocrinology, 2014
Objective. We compared the characteristics of patients with Cushing’s disease alone with those of patients with Cushing’s disease and hyperprolactinemia. Methods. Eighty-four patients were enrolled between 2002 and 2011, in a hospital in China. Clinical,
Cheng Huan   +4 more
doaj   +1 more source

Alcohol and the endocrine system: A critical review of disruptions, potential mechanisms, and health implications

open access: yesAlcohol, Clinical and Experimental Research, Volume 50, Issue 1, January 2026.
The endocrine system coordinates whole body cellular function and maintains homeostasis. Alcohol impacts the integrity of endocrine regulation at multiple sites, contributing to risk for comorbidities. Some of the alcohol‐mediated pathophysiological effects on the endocrine system include alterations in receptor expression and responsiveness, protein ...
Patricia E. Molina, Liz Simon
wiley   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

open access: yesAndrology, Volume 14, Issue 1, Page 294-302, January 2026.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann   +15 more
wiley   +1 more source

Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

open access: yesIatreia, 2016
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic
López-Clavijo, Carlos Alberto   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy